Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02677922
Title A Safety and Efficacy Study of Oral AG-120 Plus Subcutaneous Azacitidine and Oral AG-221 Plus Subcutaneous Azacitidine in Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Celgene
Indications

acute myeloid leukemia

myeloproliferative neoplasm

myelodysplastic syndrome

Therapies

Azacitidine + Ivosidenib

Azacitidine

Azacitidine + Enasidenib

Age Groups: senior | adult
Covered Countries USA | CAN

Additional content available in CKB BOOST